Tateda K, Matsumoto T, Yamaguchi K
Mediators Inflamm. 1998; 7(3):221-3.
PMID: 9705611
PMC: 1781837.
DOI: 10.1080/09629359891171.
Dolfi A, Lupetti M, Giannessi F
Cell Tissue Res. 1981; 221(1):67-75.
PMID: 7317945
DOI: 10.1007/BF00216570.
Thomson A, Fowler E
Agents Actions. 1981; 11(3):265-73.
PMID: 7020378
DOI: 10.1007/BF01967625.
Damas J, Adam A
Experientia. 1980; 36(5):586-7.
PMID: 6900563
DOI: 10.1007/BF01965817.
Hurtrel B, Lagrange P
Clin Exp Immunol. 1981; 44(2):355-8.
PMID: 6796313
PMC: 1537360.
Desulfated carrageenans and cytotoxicity of human monocytes.
Sugawara I, Ishizaka S
Agents Actions. 1983; 13(4):354-9.
PMID: 6613749
DOI: 10.1007/BF01971488.
Activation of plasma kallikrein-kinin system and its significant role in pleural fluid accumulation of rat carrageenin-induced pleurisy.
Uchida Y, Tanaka K, Harada Y, Ueno A, Katori M
Inflammation. 1983; 7(2):121-31.
PMID: 6345379
DOI: 10.1007/BF00917817.
Generation and maintenance of immune interferon-producing cells induced by allogeneic stimulation in mice.
Ito Y, Aoki H, Kimura Y, Takano M, Maeno K, Shimokata K
Infect Immun. 1980; 29(2):383-9.
PMID: 6163710
PMC: 551129.
DOI: 10.1128/iai.29.2.383-389.1980.
NK activity in carrageenan-treated mice.
Quan P, Kolb J, Lespinats G
Immunology. 1980; 40(4):495-503.
PMID: 6159311
PMC: 1458092.
Spectrum and possible mechanism of carrageenan cytotoxicity.
Catanzaro P, Schwartz H, GRAHAM Jr R
Am J Pathol. 1971; 64(2):387-404.
PMID: 5142272
PMC: 2047576.
Mechanism of the congestion of lymph nodes induced by ellagic acid in rats.
Damas J, Adam A
Agents Actions. 1987; 22(3-4):202-8.
PMID: 3445816
DOI: 10.1007/BF02009047.
The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion.
Silverberg M, Diehl S
Biochem J. 1987; 248(3):715-20.
PMID: 2449171
PMC: 1148608.
DOI: 10.1042/bj2480715.
Kinins and peritoneal exudates induced by carrageenin and zymosan in rats.
Damas J, Bourdon V, Adam A
Br J Pharmacol. 1990; 101(2):418-22.
PMID: 2257442
PMC: 1917702.
DOI: 10.1111/j.1476-5381.1990.tb12724.x.
Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival.
Franks A, Kujawa K, Yaffe L
Infect Immun. 1991; 59(8):2609-14.
PMID: 1855980
PMC: 258063.
DOI: 10.1128/iai.59.8.2609-2614.1991.
The in vitro and in vivo effects of carrageenin on humoral and cellular factors of natural resistance.
Miler I, Stelzner A
Folia Microbiol (Praha). 1975; 20(3):251-60.
PMID: 1095463
DOI: 10.1007/BF02876787.
Toxicity of various carrageenans in the mouse.
Thomson A, Horne C
Br J Exp Pathol. 1976; 57(4):455-9.
PMID: 971409
PMC: 2041165.
Edema formation and neutrophil mobilization in the neutropenic rat.
Gilchrest H, WATNICK A
Agents Actions. 1977; 7(5-6):529-32.
PMID: 602877
DOI: 10.1007/BF02111125.
A histopathological study of the effects of intravenously administered lambda carrageenan in the mouse, with particular reference to the macrophage system.
Steele P, Lowes J
Br J Exp Pathol. 1979; 60(4):358-65.
PMID: 508585
PMC: 2041482.
A re-evaluation of the role of macrophages in carrageenan-induced immunosuppression.
Rumjanek V, Watson S, Sljivic V
Immunology. 1977; 33(3):423-32.
PMID: 332622
PMC: 1445637.
Alleviation of carrageenan-induced hepatotoxicity and acronecrosis by aprotinin.
Fowler E, Thomson A, Horne C
Br J Exp Pathol. 1977; 58(3):260-7.
PMID: 301397
PMC: 2041150.
